{"disease":{"id":"coagulation-factor-deficiency","name":"coagulation factor deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06481995","title":"SWIFT - SWIss Factor XIII Trial in PPH","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":988,"lead_sponsor_name":"Christian Haslinger","has_results":false},{"nct_id":"NCT03634215","title":"Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma","phase":"","overall_status":"COMPLETED","enrollment_count":357,"lead_sponsor_name":"Masaryk Hospital Krajská zdravotní a.s.","has_results":false},{"nct_id":"NCT03782025","title":"Effect of Vitamin K in Critically Ill Patients","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT03273998","title":"Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03876301","title":"Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06014320","title":"Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03188913","title":"Factor XIII in Major Burns Coagulation","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT03734588","title":"Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}